Patents by Inventor Min-Wen Kuo

Min-Wen Kuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITIONS FOR USE IN TREATING PAIN
    Publication number: 20220071934
    Abstract: Provided is a pharmaceutical composition for use in treating postsurgical pain. The pharmaceutical composition comprises a lipid-based complex. The lipid-based complex comprises an amide-type anesthetic and at least one lipid, wherein a molar ratio of the amide-type anesthetic to the at least one lipid of the lipid-based complex is at least 0.5:1. The total amount of the amide-type anesthetic is at least 1.5 to 5 times of a standard therapeutic dose for treating postsurgical pain with the amide-type anesthetic to achieve an improved pain control with desired prolonged analgesic effect.
    Type: Application
    Filed: February 26, 2020
    Publication date: March 10, 2022
    Inventors: TIEN-TZU TAI, YUN-LONG TSENG, SHEUE-FANG SHIH, MIN-WEN KUO, CARL OSCAR BROWN, HUI-TING WANG, WEENEE YEUN NG JAO, PEI-HSIEN HU, WAN-NI YU, KEELUNG HONG, HAO-WEN KAO, YI-YU LIN
  • DOSE REGIME FOR CAMPTOTHECIN DERIVATIVES
    Publication number: 20140135357
    Abstract: The present invention is directed to a method of inhibiting cancer cell growth, comprising administering a pharmaceutical composition to a subject in need thereof. The pharmaceutical composition comprises at least one camptothecin derivative or a pharmaceutically acceptable salt thereof; and at least one PEG phospholipid, and provides a sustained release of topotecan as an active ingredient.
    Type: Application
    Filed: November 12, 2013
    Publication date: May 15, 2014
    Applicants: Taiwan Liposome Company, Ltd., TLC Biopharmaceuticals, Inc.
    Inventors: Yun-Long TSENG, Keelung HONG, Min-Wen KUO
  • Camptothecin derivatives and uses thereof
    Patent number: 8168648
    Abstract: The present invention provides two new camptothecin derivatives, which were identified as S,R- and S,S-topotecan lactates, respectively. Both compounds have anticancer activities. Pharmaceutical compositions of the new camptothecin derivatives, and cancer therapies with the new camptothecin derivatives or their pharmaceutical compositions were also provided.
    Type: Grant
    Filed: March 5, 2010
    Date of Patent: May 1, 2012
    Assignees: Taiwan Liposome Co., Ltd., TLC Biopharmaceuticals, Inc.
    Inventors: Min-Wen Kuo, Yung-Hsu Chan, Yun-Long Tseng, Siong-Tern Liew, Keelung Hong
  • NEW CAMPTOTHECIN DERIVATIVES AND USES THEREOF
    Publication number: 20100227877
    Abstract: The present invention provides two new camptothecin derivatives, which were identified as S,R- and S,S-topotecan lactates, respectively. Both compounds have anticancer activities. Pharmaceutical compositions of the new camptothecin derivatives, and cancer therapies with the new camptothecin derivatives or their pharmaceutical compositions were also provided.
    Type: Application
    Filed: March 5, 2010
    Publication date: September 9, 2010
    Applicants: Taiwan Liposome Co. Ltd., TLC Biopharmaceuticals, Inc.
    Inventors: Min-Wen Kuo, Yung-Hsu Chan, Yun-Long Tseng, Siong-Tern Liew, Keelung Hong